Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC).
about
Macrocyclic histone deacetylase inhibitorsSearch for the pharmacophore of histone deacetylase inhibitors using pharmacophore query and docking studyDesign and Evaluation of Tumor-Specific Dendrimer Epigenetic Therapeutics.Differential effects of histone deacetylase inhibitors in tumor and normal cells-what is the toxicological relevance?Histone deacetylase inhibitors (HDACIs). Structure--activity relationships: history and new QSAR perspectives.Asymmetric organocatalytic addition reactions of maleimides: a promising approach towards the synthesis of chiral succinimide derivatives.Natural and Synthetic Macrocyclic Inhibitors of the Histone Deacetylase Enzymes.Antiglycation, radical scavenging, and semicarbazide-sensitive amine oxidase inhibitory activities of acetohydroxamic acid in vitro.SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors.Effects of chirality on the antifungal potency of methylated succinimides obtained by Aspergillus fumigatus biotransformations. comparison with racemic ones.A simple primary amine thiourea catalyzed highly enantioselective conjugate addition of alpha,alpha-disubstituted aldehydes to maleimides.Chemoenzymatic synthesis and application of bicyclo[2.2.2]octadiene ligands: increased efficiency in rhodium-catalyzed asymmetric conjugate additions by electronic tuning.Phospha-Michael addition reaction of maleimides employing N-heterocyclic phosphine-thiourea as a phosphonylation reagent: synthesis of 1-aryl-2,5-dioxopyrrolidine-3-yl-phosphonate derivatives.Direct synthesis of chiral 3-arylsuccinimides by rhodium-catalyzed enantioselective conjugate addition of arylboronic acids to maleimides.
P2860
Q24629065-5A0325AC-34DE-4B30-9599-CA8280EC438EQ35542579-1BB8D83F-5DFD-46A7-B403-DA05BA9FEF8CQ35908427-CB7240D4-3B19-4BF7-9F08-DE8B06F941EEQ36179533-748931D6-DDE8-4B86-9E35-661CF8EEDB42Q37693855-0491DB04-32D1-4053-9A28-589C5E260CDEQ38045277-DD04718A-12C2-4A8B-A0A6-FF8255A53B78Q38982458-F3B3D59C-55CC-4A3F-9B3E-315754B5BD77Q40112278-84AF0533-9820-4510-8392-BA458416EEA2Q41487113-A0A40BE1-3C0D-4F2B-AEFC-DB7AF49EBD5EQ42711233-6B36ECFF-1A09-42A2-AA7A-E99F7F2945CBQ43030115-7CC07CA0-ABD4-440E-A73C-DBB411EDB515Q43129716-F11326D5-F1EB-41B8-B414-05BE87761194Q52859320-2AD47D14-83CE-4519-A8D9-B9A240756ACEQ53214407-068D287E-7933-4D5D-9D75-091EE5F07B13
P2860
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC).
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC).
@en
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase
@nl
type
label
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC).
@en
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase
@nl
prefLabel
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC).
@en
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase
@nl
P2093
P1476
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC).
@en
P2093
H Robin Heyman
Junling Li
Keith B Glaser
Lori J Pease
Michael L Curtin
Michael R Michaelides
Patrick A Marcotte
Robert B Garland
Robin R Frey
Steven K Davidsen
P304
P356
10.1016/S0960-894X(02)00622-4
P407
P577
2002-10-01T00:00:00Z